Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,507
+$63 QoQ
Shares Held
16
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,583
of 1,603 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Corsicana & Co. holds $7,494,081 across 12 Drug Manufacturers - General names. NVS ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,904 | $3,785,168 | |
| 2 | ABBV |
AbbVie Inc.
|
11,827 | $2,976,146 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,665 | $342,452 | |
| 4 | LLY |
ELI LILLY & Co
|
228 | $273,470 | |
| 5 | PFE |
Pfizer Inc
|
2,615 | $62,969 | |
| 6 | AZN |
Astrazeneca PLC
|
100 | $18,962 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
310 | $17,862 | |
| 8 | AMGN |
Amgen Inc
|
16 | $5,793 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,507 | 16 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,444 | 16 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,205 | 16 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,051 | 16 | Shares | Sole | 2025-10-10 | |
| 2022-09-30 | $1,216 | 16 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,352 | 16 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,404 | 16 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $1,399 | 16 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $1,308 | 16 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,459 | 16 | Shares | Sole | 2021-07-01 | |
| No filing history on record for this holder in this stock. | ||||||